BCDA BioCardia, Inc.
BioCardia, Inc. (BCDA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: September 29, 2026 , by Altman Peter .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO | Buy | 1,000 | $1.03 | $1.0K | 384,885 | |
| Altman Peter | President and CEO | Buy | 1,900 | $1.05 | $2.0K | 383,885 | |
| Altman Peter | President and CEO | Buy | 800 | $1.09 | $872 | 381,985 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.